Related references
Note: Only part of the references are listed.In Vivo Activities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum β-Lactamases, in the Thighs of Neutropenic Mice
W. A. Craig et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model
Brian VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa
T. W. Felton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Impact of Different Carbapenems and Regimens of Administration on Resistance Emergence for Three Isogenic Pseudomonas aeruginosa Strains with Differing Mechanisms of Resistance
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Pharmacokinetics and Safety of CXA-101, a New Antipseudomonal Cephalosporin, in Healthy Adult Male and Female Subjects Receiving Single- and Multiple-Dose Intravenous Infusions
Yigong Ge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Bacterial-population responses to drug-selective pressure:: Examination of garenoxacin's effect on Pseudomonas aeruginosa
VH Tam et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of gram-negative pathogens
SM Bhavnani et al.
CLINICAL INFECTIOUS DISEASES (2003)
Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients
AD Harris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
